Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01244672 · ClinicalTrials.gov registry record · NA
Trans-anal Hemorrhoidal Dearterialization (THD) vs. Hemorrhoidectomy
A NA study of Hemorrhoids, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01244672 is a NA study of Hemorrhoids that has completed, run by Stony Brook University. The registered enrollment target is 40 participants, below the 78-participant average among 3 other Hemorrhoids trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01244672, a NA study of Hemorrhoids, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the frequency and severity of postoperative( after surgery) pain between two surgical techniques for treating severe hemorrhoids. The two techniques are called: transanal hemorrhoidal dearterialization (THD) and standard surgical excision (removal) of the hemorrhoids
Conditions Studied
Interventions
- PROCEDURE Ferguson
- PROCEDURE THD
Study Locations (1)
New York
- State University Hospital Medical Center - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01244672
The ClinicalTrials.gov registry entry for NCT01244672 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 78-participant average among 3 other Hemorrhoids trials with a reported enrollment target (49% lower). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemorrhoids appearing as the primary indexed condition, and to 2 interventions - of which Ferguson is the first listed.
NCT01244672 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01244672 about?
NCT01244672 is a clinical study titled "Trans-anal Hemorrhoidal Dearterialization (THD) vs. Hemorrhoidectomy". The purpose of this study is to compare the frequency and severity of postoperative( after surgery) pain between two surgical techniques for treating severe hemorrhoids. The two techniques are called: transanal hemorrhoidal dearterialization (THD) and standard surgical excision (removal) of the hemo...
What is the current status of trial NCT01244672?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2009-12. Estimated completion is 2012-09.
What conditions does trial NCT01244672 study?
This clinical trial studies the following conditions: Hemorrhoids.
What interventions are being tested in trial NCT01244672?
The interventions under investigation include: Ferguson (PROCEDURE), THD (PROCEDURE).
Who is sponsoring clinical trial NCT01244672?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01244672 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemorrhoids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.